Skip to main content


FDA authorizes emergency use of the antibody cocktail given to President Trump to treat Covid-19

By CNN  
   November 22, 2020

The US Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron's antibody cocktail to treat Covid-19 in high-risk patients with mild to moderate disease. President Donald Trump received the therapy, called REGEN-COV2, when he was hospitalized for coronavirus. The treatment has to be infused into the bloodstream and is meant to mimic an immune response to infection.

Full story

Get the latest on healthcare leadership in your inbox.